ABOUT SWISS MEDICA XXI CLINIC
We started in 2011 in Lugano, Switzerland, when a group of medical specialists created a project to apply their knowledge in the field of regenerative medicine. They determined to realize the use of cell products in the treatment of various diseases, primarily those associated with the damage of tissues.
What Is Our Capability?
Swiss Medica specializes in the most cutting edge stem cell therapies. We use more than 10 cell products, among them multipotent mesenchymal stromal cells (MMSCs), stromal vascular fraction (SVF), fibroblasts, hematopoietic stromal cells, regulatory T-cells, dendritic cell vaccines and mononuclear cells (MNC).
In our laboratories we can cultivate and cryopreserve the patient’s own cells as well as donor cells, including placental cells. We also use all types of cell product administration (intravenous, intramuscular, local injections, etc.) to increase the likelihood of getting the intended result.
The Diseases We Treat
Since 2011 we have worked to develop experience in the application of cell products for the treatment of a large number of diseases:
• multiple sclerosis;
• arthritis & osteoarthritis;
• other rheumatic diseases;
• post-stroke condition;
• autism;
• diabetes type 2;
• trophic ulcers;
• diabetic foot;
• COPD;
• obesity;
• liver cirrhosis;
• chronic pancreatitis;
• erectile dysfunction;
• post-irradiation rectovaginal fistulas;
• Parkinson’s disease;
• dementia,
and many other disorders.
+ anti-ageing.
Departments of Swiss Medica
The headquarter of Swiss Medica is in Goldach (St. Gallen, Switzerland). Our inpatient clinics are located in Austria (currently under renovation), Russia and Serbia. 
At Swiss Medica, patients undergo full-scale therapy consisting of cell product introduction and rehabilitation therapies, such as IMR therapy, shockwave, laser, and ultraviolet blood irradiation, plasmapheresis, extracorporeal spark wave, etc.

Swiss Medica XXI Century

Org chart

Teams

Offices

Similar companies